Dual-bioactivity-based liquid chromatography-coupled quadrupole time-of-flight mass spectrometry for NF-κB inhibitors and β2AR agonists identification in Chinese Medicinal Preparation Qingfei Xiaoyan Wan

Analytical and Bioanalytical Chemistry

Volumn 404, Issue 8, 2012, Pages 2445-2452

  Cheng, Binfeng ^a   Hou, Yuanyuan ^a   Wang, Liqiang ^a   Dong, Linyi ^b   Peng, Jiamin ^a   Bai, Gang ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

2 adrenergic receptor agonists; Constituent identification; Dual bioactive target; NF B inhibitors; Qingfei XiaoyanWan; UPLC QTOF MS

Indexed keywords

ADRENERGIC RECEPTORS; ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY EFFECTS; BIOACTIVE COMPOUNDS; CHEMOKINES; CHLOROGENIC ACIDS; CHOLIC ACIDS; CLINICAL THERAPY; COMPLEX DISEASE; CYTOKINES; FUNCTIONAL EVALUATION; HUMAN CELLS; LUCIFERASE REPORTER ASSAYS; MEDICINAL PREPARATION; MULTITARGET; QINGFEI XIAOYANWAN; QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; RAPID DETERMINATION; RAPID SCREENING; STRUCTURAL TYPE; TIME OF FLIGHT MASS SPECTROMETRY; TRADITIONAL CHINESE MEDICINE; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY; UPLC/QTOF-MS;

DIAGNOSIS; DISEASES; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS;

MASS SPECTROMETRY;

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; HUMAN; LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; TIME;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; CELL LINE; CHROMATOGRAPHY, LIQUID; DRUG DELIVERY SYSTEMS; DRUGS, CHINESE HERBAL; HUMANS; MOLECULAR STRUCTURE; NF-KAPPA B; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84870922316     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6332-9     Document Type: Article

References (41)

1. Sams-Dodd F (2005) Target-based drug discovery: is something wrong? Drug Discov Today 10:139-147
2. Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3:711-716
3. Keith CT, Borisy AA, Stockwel BR (2005) Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 4:71-78
4. Petrelli A, Giordano S (2008) From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. Curr Med Chem 15:422-432
5. Csermely P, Agoston V, Pongor S (2005) The efficiency of multitarget drug: the network approach might help drug design. Trends Pharmacol Sci 26:178-182
6. Wermuth CG (2004) Multitarget drug: the end of the 'one-targetone- disease' philosophy? Drug Discov Today 9:826-827
7. Gertsch J (2011) Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures. Planta Med 77:1086-1098
8. Ulrich-Merzenich G, Zeitler H, Jobst D, Panek D, Vetter H, Waqner H (2007) Application of the '-Omic-' technologies in phytomedicine. Phytomedicine 14:70-82
9. WangM, Lamers R, Korthout H, Nesselrooij J,Witkamp RF,Heijden R, Voshol PJ, Havekes LM, Verpoorte R, Greef J (2005) Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecule pharmacology. Phytother Res 19:173-182
10. Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461-477
11. Ortholand JY, Ganesan A (2004) Natural products and combinatorial chemistry: back to the future. Curr Opin Chem Biol 8:271-280
12. Cohen MH, Sandler L, Hrbek A, Davis RB, Eisenberg DM (2005) Policies pertaining to complementary and alternative medical therapies in a random sample of 39 academic health centers. Altern Ther Health Med 11:36-40
13. Zhou JL, Xin GZ, Shi ZQ (2010) Characterization and identification of steroidal alkaloids in Fritillaria species using liquid chromatography coupled with electrospray ionization quadrupole timeof- flight tandem mass spectrometry. J Chromatogr A 1217:7109- 7122
14. Zeng J, Zhang X, Guo Z, Feng J, Zeng J, Xue X, Liang X (2012) Separation and identification of flavonoids from complex samples using off-line two-dimensional liquid chromatography tandem mass spectrometry. J Chromatogr A 1220:50-56
15. Jiao L, Gao S, Zhang F, Li H (2008) Quantification of components in overlapping peaks from capillary electrophoresis by using continues wavelet transform method. Talanta 75:1061-1067
16. Sýkora J, Bernásek P, Zarevúcká M, Kurfürst M, Sovová H, Schraml J (2007) High-performance liquid chromatography with nuclear magnetic resonance detection-A method for quantification of α- and γ-linolenic acids in their mixtures with free fatty acids. J Chromatogr A 1139:152-155
17. Cheng XL, Wei F, Xiao XY, Zhao YY, Shi Y, Liu W, Zhang P, Ma SC, Tian SS, Lin RC (2012) Identification of five gelatins by ultra performance liquid chromatography/time-of-flight mass spectrometry (UPLC/Q-TOF-MS) using principal component analysis. J Pharm Biomed Anal 62:191-195
18. Zhang J, Jin Y, Dong J, Xiao Y, Feng J, Xue X, Zhang X, Liang X (2009) Systematic screening and characterization of tertiary and quaternary alkaloids from corydalis yanhusuo W.T. Wang using ultra-performance liquid chromatography-quadrupole-time-offlight mass spectrometry. Talanta 78:513-522
19. Halai R, Cooper MA (2012) Using label-free screening technology to improve efficiency in drug discovery. Expert Opin Drug Discov 7:123-131
20. Warzecha CC, Hovhannisyan R, Carstens RP (2012) Dynamic fluorescent and luminescent reporters for cell-based splicing screens. Methods Mol Biol 867:273-287
21. Frearson JA, Collie IT (2009) HTS and hit finding in academia - from chemical genomics to drug discovery. Drug Discov Today 14:1150-1158
22. Taylor DR, Bateman ED, Boulet L-P, Boushey HA, Busse WW, Casale TB et al (2008) A new perspective on concepts of asthma severity and control. Eur Respir J 32:545-554
23. Morphy R, Rankovic Z (2009) Designing multiple ligands - medicinal chemistry strategies and challenges. Curr Pharm Des 15:587-600
24. EdwardsMR, Bartlett NW, Clarke D, Birrell M, BelvisiM, Johnston SL (2009) Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther 121:1-13
25. Hou Y, Cao X, Dong L, Wang L, Cheng B, Shi Q, Luo X, Bai G (2012) Bioactivity-based liquid chromatography-coupled electrospray ionization tandem ion trap/time of flight mass spectrometry for β2AR agonist identification in alkaloidal extract of Alstonia scholaris. J Chromatogr A 1227:203-209
26. Shi Q, Hou Y, Yang Y, Bai G (2011) Protective effects of glycyrrhizin against β2-adrenergic receptor agonist-induced receptor internalization and cell apoptosis. Biol Pharm Bull 34:609-617
27. Zhou J, Xie G, Yan X (2009) Chemical components of source plants in traditional Chinese medicine. Science Press, Beijing
28. Wang HY, Yang JS (1993) Studies on the chemical constituents of Arctium lappa L. Yao Xue Xue Bao 28:911-917
29. Dinelli G, Marotti I, Bosi S, Benedettelli S, Ghiselli L, Cortacero-Ramírez S, Carrasco-Pancorbo A, Segura-Carretero A, Fernández-Gutiérrez A (2007) Lignan profile in seeds of modern and old Italian soft wheat (Triticum aestivum L.) cultivars as revealed by CE-MS analyses. Electrophoresis 28:4212-4219
30. Vansal SS, Feller DR (1999) Direct effects of ephedrine isomers on human β-adrenergic receptor subtypes. Biochem Pharmacol 58:807-810
31. Kee VR (2003) Hemodynamic pharmacology of intravenous vasopressors. Crit Care Nurse 23:79-82
32. Lee JY, Cho BJ, Park TW, Park BE, Kim SJ, Sim SS, Kim CJ (2010) Dibenzylbutyrolactone lignans from Forsythia koreana fruits attenuate lipopolysaccharide-induced inducible nitric oxide synthetase and cyclooxygenase-2 expressions through activation of nuclear factor-κB and mitogen-activated protein kinase in RAW264.7 cells. Biol Pharm Bull 33:1847-1853
33. Zhao F,Wang L, Liu K (2009) In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium Lappa L., through inhibition on iNOS pathway. J Ethnopharmacol 122:457-462
34. Yoo HH, Park JH, Kwon SW (2006) An anti-estrogenic lignan glycoside, tracheloside, from seeds of Carthamus tinctorius. Biosci Biotechnol Biochem 70:2783-2785
35. Shan J, Fu J, Zhao Z, Kong X, Huang H, Luo L, Yin Z (2009) Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-κB and JNK/AP-1 activation. Int Immunopharmacol 9:1042-1048
36. Yun KJ, Koh DJ, Kim SH, Park SJ, Ryu JH, Kim DG, Lee JY, Lee KT (2008) Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-kb inactivation. J Agric Food Chem 56:10265-10272
37. Hirano F, Tanada H, Makino Y, Okamoto K, Hiramoto M, Handa H, Makino I (1996) Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis 17:427-433
38. Duggan SP, Behan FM, Kirca M, Smith S, Reynolds JV, Long A, Kelleher D (2010) An integrative genomic approach in oesophageal cells identifies TRB3 as a bile acid responsive gene, downregulated in Barrett's oesophagus, which regulates NF-κB activation and cytokine levels. Carcinogenesis 31:936-945
39. Shah SA, Volkov Y, Arfin Q, Abdel-Latif MM, Kelleher D (2006) Ursodeoxycholic acid inhibits interleukin beta 1 and deoxycholic acid-induced activation of NF-κB and AP-1 in human colon cancer cells. Int J Cancer 118:532-539
40. Sun J, Mustafi R, Cerda S, Chumsangsri A, Xia YR, Li YC, Bissonnette M (2008) Lithocholic acid down-regulation of NF- κB activity through vitamin D receptor in colonic cancer cells. J Steroid Biochem Mol Biol 111:37-40
41. Joo SS, Won TJ, Lee DI (2004) Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch Pharm Res 27:954-960